Ovarian Cancer Information Center
Each year in the United States, more than 21,000 women will be diagnosed with ovarian cancer. Because ovarian cancer is often detected at an advanced stage when it is difficult to treat, researchers continue to explore new approaches to prevention and early detection.
Advances in surgery and chemotherapy have contributed to improved ovarian cancer survival, and it is estimated that there are more than 174,000 ovarian cancer survivors in the United States today. In addition, advances in supportive care have made ovarian cancer treatment more tolerable, leading to improved quality of life.
Understanding ovarian cancer treatment options, the role of different doctors specializing in the treatment of ovarian cancer, and how and when to access new and innovative ovarian cancer treatment options available through clinical trials is essential in order to achieve the best outcome from ovarian cancer treatment.
The Cancer Consultants Ovarian Cancer Information Center has been designed to help patients understand options for ovarian cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of ovarian cancer.
Headline Ovarian Cancer News 
BRCA Mutations Influence Ovarian Cancer Outcomes
Women with a BRCA2 mutation have best survival.
Avastin Delays Progression of Ovarian Cancer but May Not Improve Overall Survival
Two Phase III trials produce similar results
Myotonic Muscular Dystrophy Linked with Increased Cancer Risk
Risk increased for several cancer types.
Ovarian Cancer Tips
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Ovarian Cancer Management
Inspiration, Hope & Resources
National Ovarian Cancer Coalition Where do you go when you’re first delivered the news: “You have cancer”? For...
SHARE: Self-help for Women with Breast or Ovarian Cancer Nancy Singleton was diagnosed with ductal carcinoma in situ (DCIS) in February 2005....
Ovarian Cancer National Alliance “People want to be involved,” says Cara Tenenbaum of the survivors, families,...
Ovarian Cancer Clinical Trials
GOG0213 – AA Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
GOG-0218 – Phase III Trial of Carboplatin and Paclitaxel Plus Placebo versus Carboplatin and Paclitaxel Plus Concurrent Bevacizumab followed by Placebo, versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated, Suboptimal Advanced Stage Epithelial Ovarian and Primary Peritoneal Cancer
INST0708C – Biological Study: Assessment of Genetic Alterations in the Signaling Network as Prognostic Markers in Ovarian Cancer
 |
 |
 |
 |
